Combat Dengue

COMBAT is an ambitious initiative at the forefront of dengue research and pandemic preparedness, pioneering innovative antiviral strategies to alleviate the burden of dengue infection while deepening our understanding of its complex pathogenesis through cutting-edge multi-modal technologies.

The project stands at a pivotal crossroads in interdisciplinary research, merging the domains of biological science, physics, nanotechnology, computer science, and (bio)engineering. By crafting policy frameworks to address dengue threats in Europe and establishing a state-of-the-art interdisciplinary hub for scalable and affordable pandemic preparedness, COMBAT aims to revolutionize global health responses and equip communities to face emerging health crises with resilience and efficiency.

Coordinating Team

Ujjwal Neogi

Coordinator, Senior Lecturer, KI

Indranil Sinha

Scientific Manager

Hanna Gador

Project Manager

Anthony Forsström

Project Finance Manager

Christina Sundqvist

Website Manager

News

EU supports DZL researchers in the fight against Dengue fever

A small bite with devastating consequences: Each year, up to 100 million people worldwide contract Dengue fever, with the numbers on the rise. Mosquitoes transmit this viral disease, which causes severe muscle and joint pain and can lead to death in severe cases.

KI to coordinate EU-funded initiative to combat global dengue epidemic

As part of the response to the escalating threat of a global dengue fever epidemic, a new interdisciplinary EU-funded research initiative has been established with KI as coordinator. The COMBAT project aims to develop solutions to manage and mitigate the dengue virus, which causes 100 million infections and 10,000 deaths annually in 141 countries. In addition to the human suffering, the virus causes an economic burden of over EUR 8 billion globally.

COMBATing Dengue with Brain-on-Chip Technology

In 2023, the World Health Organization (WHO) recorded 6.5 million cases of dengue infections in more than 80 countries. Despite this staggering number, there is currently no specific treatment for dengue infections. Together with nine international partners, OrganoVIR Labs will combine novel brain-on-chip technology with super-resolution microscopy to develop innovative solutions for dengue prevention and treatment.

Partners

KI logotype
Amsterdam UMC logotype
Justus-Liebig-Universität Giessen logotype
Lund University logotype
Bio Box Guatemala logotype
ChipNano Imaging logotype
Olink logotype
React4Life logotype
Mizzou logotype
Artemis logotype
Manipal logotype
NIBG logotype
RCB logotype
MAX Healthcare logotype
University of Oslo logotype